Skip to search formSkip to main contentSkip to account menu

FIGO Stage IB2

A FIGO stage term that applies to gynecologic cancers. For cervical cancer, it refers to clinically visible lesions that measure more than 4.0 cm in… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Patterns of recurrence and prognosis in locally advanced FIGO stage IB2 to IIB cervical cancer: Retrospective multicentre study from the FRANCOGYN group.
2018
2018
Definite chemoradiotherapy is a competent treatment option in FIGO stage IB2 cervical cancer compared with radical surgery +/- neoadjuvant chemotherapy.
2018
2018
Comparison of pelvic and para-aortic lymphadenectomy versus para-aortic lymphadenectomy alone for locally advanced FIGO stage IB2 to IIB cervical cancer using a propensity score matching analysis…
Review
2017
Review
2017
FIGO stage IB1 cervical carcinoma: Place and principles of brachytherapy.
2016
2016
Surgical Resection after Concurrent Chemoradiotherapy for Locally Advanced Cervical Carcinoma
Background: Completion surgery after chemoradiotherapy (CRT) in management of locally advanced cervical cancers (LACC) still… 
Review
2013
Review
2013
Concurrent chemoradiotherapy with low-dose daily cisplatin for high risk uterine cervical cancer: a long-term follow-up study
Objective To evaluate the clinical efficacy of concurrent chemoradiotherapy (CCRT) using daily low-dose cisplatin for cervical… 
Review
2013
Review
2013
The Comparison of Four Different Treatment Modalities in Bulky Stage Ib ve IIa Cervix Cancers
Objective: To compare the effectiveness of four different treatment modalities in International Federation of Gynecology and… 
2008
2008
Pre-operative Concomitant Radio-chemotherapy in Bulky Carcinoma of the Cervix: A Single Institution Study
Objective To evaluate the treatment results of patients (pts) with FIGO stage IB2, IIA, IIB cervical carcinoma (CC) treated with… 
Review
2007
Review
2007
Multimodality therapy for locally advanced cervical carcinoma: state of the art and future directions.
Globally, cervical cancer is the second most common cause of cancer-related mortality among women causing approximately 234,000… 
2000
2000
Synchronous primary cancers of the breast and cervix: planning multidisciplinary primary treatment [clinico-pathological conference].
Multiple metachronous primary malignancies are becoming increasingly frequent; however, multiple synchronous primary malignancies… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)